Search results for "Cyproheptadin"
showing 4 items of 4 documents
Reduction of negative alliesthesia for sweet gustatory stimuli by cyproheptadine, a serotonin antagonist
1990
Cyproheptadine (CH) is a serotonin antagonist that increases food intake and body weight. In order to elucidate its mechanism of action on the control of food intake, hunger ratings, pleasure-displeasure to sweet gustatory stimuli and negative alliesthesia induced by a 50 g glucose load were compared in 14 healthy subjects after they had received a placebo or 16 mg of CH. Cyproheptadine did not affect the hunger rating, nor the affective rating in fasted subjects, but it reduced significantly the negative alimentary alliesthesia induced by the glucose load. It was concluded that CH increases food intake more by reducing satiation than by increasing hunger. This is in line with the anti-sero…
Anti-Inflammatory Triterpenes from Pistacia terebinthus Galls
2002
From the galls of Pistacia terebinthus we obtained an extract that proved to be effective against chronic and acute inflammation. Now we report on the isolation and identification of three triterpenes: two tirucallane-type lanostanoids and one oleanane, which we have identified as masticadienonic acid (1), masticadienolic acid (2), and morolic acid (3), respectively. All of them showed effectiveness on the mouse ear inflammation induced by repeated applications of 12-O-tetradecanoylphorbol 13-acetate and on the phospholipase A2-induced foot paw edema. The pharmacological activity of the compounds was ratified by a histological study of the ear samples. In addition, they inhibited leukotrien…
Die Wirkung von Cyproheptadin auf die Winterschlafbereitschaft und die jahreszeitlichen Körpergewichtsänderungen beim sibirischen BackenhörnchenTamia…
1971
The effect of cyproheptadin (4 mg/kg per os) on the typical weight cycle of sibirian chipmunksTamias (Eutamias)sibiricus before and during the hibernation period was studied. The substance leads to a complete inhibition of hibernation and the bodyweight reaches a lower level than in control animals.
Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicity.
1975
The epoxide metabolites of two clinically used drugs and an experimental psychotropic agent, carbamazepine 10,11-oxide, cyproheptadine 10,11-oxide and cyclobenzaprine 10,11-oxide, were fully devoid of any mutagenic activity under conditions where K-region-epoxide metabolites of some known carcinogens, such as benzo (a)pyrene, proved to be potent frameshift mutational agents for Salmonella typhimurium TA 1537 and TA 1538. All epoxides tested were non-mutagenic for TA 1535, designed to detect substitution mutations. The 10,11-epoxides of the three drugs, carbamazepine, cyproheptadine and cyclobenzaprine, were not cytotoxic to any of the bacterial tester strains used, precluding that mutagenic…